Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

10-Year follow-up of 621 patients treated using high-dose rate brachytherapy as ambulatory boost technique in conservative breast cancer treatment.

Quéro L, Guillerm S, Taright N, Michaud S, Teixeira L, Cahen-Doidy L, Bourstyn E, Espié M, Hennequin C.

Radiother Oncol. 2017 Jan;122(1):11-16. doi: 10.1016/j.radonc.2016.06.014. Epub 2016 Jul 26.

PMID:
27474504
2.

p53 in breast cancer subtypes and new insights into response to chemotherapy.

Bertheau P, Lehmann-Che J, Varna M, Dumay A, Poirot B, Porcher R, Turpin E, Plassa LF, de Roquancourt A, Bourstyn E, de Cremoux P, Janin A, Giacchetti S, Espié M, de Thé H.

Breast. 2013 Aug;22 Suppl 2:S27-9. doi: 10.1016/j.breast.2013.07.005. Review.

3.

Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15.

Lehmann-Che J, Hamy AS, Porcher R, Barritault M, Bouhidel F, Habuellelah H, Leman-Detours S, de Roquancourt A, Cahen-Doidy L, Bourstyn E, de Cremoux P, de Bazelaire C, Albiter M, Giacchetti S, Cuvier C, Janin A, Espié M, de Thé H, Bertheau P.

Breast Cancer Res. 2013 May 11;15(3):R37. doi: 10.1186/bcr3421.

4.

Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches.

Lehmann-Che J, Amira-Bouhidel F, Turpin E, Antoine M, Soliman H, Legres L, Bocquet C, Bernoud R, Flandre E, Varna M, de Roquancourt A, Plassa LF, Giacchetti S, Espié M, de Bazelaire C, Cahen-Doidy L, Bourstyn E, Janin A, de Thé H, Bertheau P.

Br J Cancer. 2011 May 24;104(11):1739-46. doi: 10.1038/bjc.2011.135. Epub 2011 May 3.

5.

[Sentinel node biopsy in breast cancer].

Hindié E, Groheux D, Espie M, Bourstyn E, Toubert ME, Sarandi F, de Roquancourt A, Giacchetti S, Cuvier C, Cahen-Doidy L, Teyton P, Misset JL, Maylin C, Moretti JL.

Bull Cancer. 2009 Jun;96(6):713-25. doi: 10.1684/bdc.2009.0879. French.

6.

[Invasive lobular carcinoma of the breast: specific diagnosis and evolution].

Espié M, Hocini H, Cuvier C, Giacchetti S, Bourstyn E, de Roquancourt A.

Gynecol Obstet Fertil. 2006 Jan;34(1):3-7. Epub 2006 Jan 6. French.

PMID:
16406734
7.

[Breast lobular carcinoma in situ: diagnosis and evolution].

Espié M, Hocini H, Cuvier C, Giacchetti S, Bourstyn E, de Roquancourt A.

Gynecol Obstet Fertil. 2005 Dec;33(12):964-9. Epub 2005 Dec 1. Review. French.

PMID:
16324870
8.

[Neoadjuvant treatment of early breast cancer: new drugs contribution].

Giacchetti S, Cuvier C, Hocini H, Bourstyn E, de Roquancourt A, Espié M.

Bull Cancer. 2004 Dec 1;91 Suppl 4:S232-8. Review. French.

PMID:
15899614
9.

[Standards, Options and Recommendations 2004: good practice guidelines for second opinion in anatomic and surgical pathology in oncology (integral report)].

Hassoun J, Bataillard A, Voigt JJ, Coindre JM, Anger E, Bellocq JP, Bugat R, Bougnoux A, Dauplat J, Hebbar M, Gérard JP, Bourstyn E; Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC); Standards, Options and Recommendations; Ligue contre le Cancer; Société Française de Pathologie (SFP); Fédération Hospitalière de France (FHF); Fédération Nationale de Cancérologie des Centres Hospitaliers Regionaux Universitaires (FNCCHRU); Fédération Française de Cancérologie des centres hospitaliers généraux (FFCCHG).

Bull Cancer. 2004 Dec;91(12):941-57. French.

10.

Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes.

Rouzier R, Extra JM, Klijanienko J, Falcou MC, Asselain B, Vincent-Salomon A, Vielh P, Bourstyn E.

J Clin Oncol. 2002 Mar 1;20(5):1304-10.

PMID:
11870173
11.

Immunocytochemical detection of bone marrow micrometastases in colorectal carcinoma patients, using a monoclonal antibody to villin.

Rouzier R, Bourstyn E, Grozier F, Berger A, Louvard D, Robine S.

Cytometry. 2001 Oct 15;46(5):281-9.

12.

Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving surgery.

Rouzier R, Extra JM, Carton M, Falcou MC, Vincent-Salomon A, Fourquet A, Pouillart P, Bourstyn E.

J Clin Oncol. 2001 Sep 15;19(18):3828-35.

PMID:
11559720
13.

Familial invasive breast cancers: worse outcome related to BRCA1 mutations.

Stoppa-Lyonnet D, Ansquer Y, Dreyfus H, Gautier C, Gauthier-Villars M, Bourstyn E, Clough KB, Magdelénat H, Pouillart P, Vincent-Salomon A, Fourquet A, Asselain B.

J Clin Oncol. 2000 Dec 15;18(24):4053-9.

PMID:
11118466
14.

Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction.

de Cremoux P, Extra JM, Denis MG, Pierga JY, Bourstyn E, Nos C, Clough KB, Boudou E, Martin EC, Müller A, Pouillart P, Magdelénat H.

Clin Cancer Res. 2000 Aug;6(8):3117-22.

15.

[Retrospective multivariate analysis of radio-pathological correlations of nonpalpable breast lesions. Experience of the Hospital Saint-Louis].

Cottu PH, Cojean-Zelek I, Bourstyn E, de Roquancourt A, Extra JM, Perret F, Gorins A, Marty M, Espié M.

Rev Med Interne. 2000 Apr;21(4):337-43. French.

PMID:
10795326
16.

Illegitimate villin transcripts in normal bone marrow precludes detection of colon cancer micrometastases.

Salbe C, de Cremoux P, Bonneton C, Manet S, Almeida A, Magdelénat H, Bourstyn E, Robine S.

Int J Biol Markers. 2000 Jan-Mar;15(1):41-3.

PMID:
10763139
17.

Is p53 a protein that predicts the response to chemotherapy in node negative breast cancer?

Degeorges A, de Roquancourt A, Extra JM, Espie M, Bourstyn E, de Cremoux P, Soussi T, Marty M.

Breast Cancer Res Treat. 1998 Jan;47(1):47-55.

PMID:
9493975
18.

[Inflammatory cancer of the breast: review and experience at Saint-Louis hospital].

Espié M, Extra JM, de Roquancourt A, Bourstyn E, Hennequin C, Morvan F, Marty M.

Arch Anat Cytol Pathol. 1995;43(1-2):36-43. Review. French.

PMID:
7794025
19.

p53 mutations and overexpression in locally advanced breast cancers.

Faille A, De Cremoux P, Extra JM, Linares G, Espie M, Bourstyn E, De Rocquancourt A, Giacchetti S, Marty M, Calvo F.

Br J Cancer. 1994 Jun;69(6):1145-50.

20.

[Macroscopic study of specimens resected from breasts].

de Roquancourt A, Zafrani B, Bourstyn E, Espié M, Brocheriou C.

Arch Anat Cytol Pathol. 1994;42(5):206-10. Review. French. No abstract available.

PMID:
7872811
21.

[Radiological location of infraclinical lesions of the breast. Technique--results--therapeutic consequences].

Bourstyn E, Marty M, Espie M, de Roquancourt A, Laval-Jeantet M, Clot P.

Chirurgie. 1994-1995;120(6-7):342. French. No abstract available.

PMID:
7768122
22.

[Promising results of bimonthly chemotherapy with high dose cyclophosphamide and epirubicin in induction treatment of inflammatory cancer of the breast].

Culine S, Extra JM, Espie M, Bourstyn E, Dieras V, Giacchetti S, Maylin C, De Rocquancourt A, Morvan F, Marty M.

Bull Cancer. 1993 Nov;80(11):994-1000. French.

PMID:
8081037
23.

Splenectomy in human immunodeficiency virus-related thrombocytopenia.

Alonso M, Gossot D, Bourstyn E, Galera MJ, Oksenhendler E, Celerier M, Clot P.

Br J Surg. 1993 Mar;80(3):330-3. Review.

PMID:
8472143
24.

[Role of marking surgery in the diagnosis of minimal breast cancers].

Bourstyn E, de Roquancourt A, Bourier J, Espié M, Laval-Jeantet M, Marty M, Clot P.

Pathol Biol (Paris). 1993 Jan;41(1):64. French. No abstract available.

PMID:
8316471
25.

Surgical restaging of advanced Hodgkin's disease after first line chemotherapy.

Fermé C, Brice P, Bourstyn E, D'Agay MF, Lepage E, Miclea JM, Fermand JP, Extra JM, Frija J, Colin P, et al.

Eur J Haematol. 1991 May;46(5):306-11.

PMID:
1710575
26.

[Splenectomy for chronic thrombocytopenic purpura].

Cohen MA, Bourstyn E, Galera MJ, Najean Y, Clot P.

Ann Chir. 1991;45(7):540-2. French.

PMID:
1755617
27.

[Cancer of the breast: intensive treatment with bone marrow autografts].

Gisselbrecht C, Lepage E, Extra JM, Espie M, Andolenko P, Morvan F, Ganem G, Gerota Y, Bourstyn E, Marty M, et al.

Bull Cancer. 1989;76(1):99-104. French.

PMID:
2653474
28.

[The place of surgery in the treatment of inflammatory breast cancers].

Bourstyn E.

Soins. 1988 Aug;(515):7-8. French. No abstract available.

PMID:
3187612
29.

[Peroperative radiotherapy].

Clot P, Bourstyn E, Roge P, Richard CA, Douard MC, Imbert A.

Soins. 1988 Aug;(515):25-7. French. No abstract available.

PMID:
3187604
30.

Splenectomy performed upon thirty-seven patients with hairy cell leukemia.

Brochard M, Sigaux F, Flandrin G, Bourstyn E, Clot P.

Surg Gynecol Obstet. 1987 Oct;165(4):305-8.

PMID:
3660194
31.

Anorexia in oesophageal carcinoma.

Belghiti J, Bourstyn E, Fékété F.

Eur J Surg Oncol. 1987 Oct;13(5):405-7.

PMID:
3478224
32.

[Spontaneous rupture of the spleen in hematologic diseases. Apropos of 2 cases].

Ricart O, Clot P, Bourstyn E, Richard CA.

Ann Chir. 1987;41(3):191-4. French. No abstract available.

PMID:
3476009
33.

Lymphadenopathy syndrome and seroconversion two months after single use of needle shared with an AIDS patient.

Vittecoq D, Autran B, Bourstyn E, Chermann JC.

Lancet. 1986 May 31;1(8492):1280. No abstract available.

PMID:
2872425
34.

Results of portal systemic shunts in Budd-Chiari syndrome.

Vons C, Smadja C, Bourstyn E, Szekely AM, Bonnet P, Franco D.

Ann Surg. 1986 Apr;203(4):366-70.

35.

[Results of portasystemic shunts in the treatment of the Budd-Chiari syndrome].

Franco D, Bourstyn E.

Gastroenterol Clin Biol. 1984 Oct;8(10):720-4. French.

PMID:
6526227
36.

[Rehabilitation, readaptation, psychological problems after surgery of cancer of the esophagus].

Bourstyn E.

Soins Chir. 1983 Dec;(34):30-1. French. No abstract available.

PMID:
6560716
37.

Surgical implications of malnutrition and immunodeficiency in patients with carcinoma of the oesophagus.

Belghiti J, Langonnet F, Bourstyn E, Fekete F.

Br J Surg. 1983 Jun;70(6):339-41.

PMID:
6407554

Supplemental Content

Loading ...
Support Center